Health-related quality of life and functioning in bipolar disorder: the impact of pharmacotherapy

References

• Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry62, 593–602 (2005).
   PubMed Web of Science ®Google Scholar
• Altshuler LL, Gitlin MJ, Mintz J et al. Subsyndromal depression is associated with functional impairment in patients with bipolar disorder. J. Clin. Psychiatry63, 807–811 (2002).
   PubMed Web of Science ®Google Scholar
• Judd LL, Akiskal HS, Schettler PJ et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch. Gen. Psychiatry59, 530–537 (2002).
   PubMed Web of Science ®Google Scholar
• Suppes T, Dennehy EB, Gibbons EW. The longitudinal course of bipolar disorder. J. Clin. Psychiatry61(Suppl. 9), 23–30 (2000).
   PubMedGoogle Scholar
• Judd LL, Akiskal HS, Schettler PJ et al. A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch. Gen. Psychiatry60, 261–269 (2003).
   PubMed Web of Science ®Google Scholar
• Hirschfeld MA, Lewis L, Vornik LA. Perceptions and impact of bipolar disorder: how far have we really come? Results of the National Depressive and Manic-Depressive Association 2000 Survey of individuals with bipolar disorder. J. Clin. Psychiatry64, 161–174 (2003).
   PubMed Web of Science ®Google Scholar
• Revicki DA, Matza LS, Flood E, Lloyd A. Bipolar disorder and health-related quality of life. Review of burden of disease and clinical trials. Pharmacoeconomics23, 583–594 (2005).
   PubMed Web of Science ®Google Scholar
• Coryell W, Schftner W, Keller M et al. The enduring psychosocial consequences of mania and depression. Am. J. Psychiatry150, 720–727 (1993).
   PubMed Web of Science ®Google Scholar
• Abood Z, Sharkey A, Webb M et al. Are patients with bipolar affective disorder socially disadvantaged? A comparison with a control group. Bipolar Disord.4, 243–248 (2002).
   PubMedGoogle Scholar
• Quanbeck CD, Stone DC, Scott CL et al. Clinical and legal correlates of inmates with bipolar disorder at time of criminal arrest. J. Clin. Psychiatry65, 198–203 (2004).
   PubMed Web of Science ®Google Scholar
• Friedman SH, Shelton MD, Elhaj O et al. Gender differences in criminality: bipolar disorder with co-occurring substance abuse. J. Am. Acad. Psychiatry Law33, 188–195 (2005).
   PubMed Web of Science ®Google Scholar
• Martinez-Aran A, Vieta E, Reinares M et al. Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. Am. J. Psychiatry161, 262–270 (2004).
   PubMed Web of Science ®Google Scholar
• Depp CA, Davis CE, Mittal D, Patterson TL, Jeste DV. Health-related quality of life and functioning of middle-aged and elderly adults with bipolar disorder. J. Clin. Psychiatry67, 215–221 (2006).
   PubMed Web of Science ®Google Scholar
• Conus P, Berk M, McGorry PD. Pharmacological treatment in the early phase of bipolar disorders: what stage are we at? Aust. NZ J. Psychiatry40, 199–207 (2006).
   PubMed Web of Science ®Google Scholar
• McElroy SL, Altshuler LL, Suppes T et al. Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am. J. Psychiatry158, 420–426 (2001).
   PubMed Web of Science ®Google Scholar
• McElroy SL. Diagnosing and treating comorbid (complicated) bipolar disorder. J. Clin. Psychiatry65(Suppl. 15), 35–44 (2004).
   PubMed Web of Science ®Google Scholar
• Regier DA, Farmer ME, Rae DS et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) study. JAMA264, 2511–2518 (1990).
   PubMed Web of Science ®Google Scholar
• Chen YW, Dilsaver SC. Comorbidity of panic disorder in bipolar illness: evidence from the Epidemiologic Catchment Area Survey. Am. J. Psychiatry152, 280–282 (1995).
   PubMedGoogle Scholar
• Chen YW, Dilsaver SC. Comorbidity for obsessive-compulsive disorder in bipolar and unipolar disorders. Psychiatry Res.59, 57–64 (1995).
   PubMed Web of Science ®Google Scholar
• Brady KT, Killeen TK, Brewerton T, Lucerini S. Comorbidity of psychiatric disorders and posttraumatic stress disorder. J. Clin. Psychiatry61(Suppl. 7), 22–32 (2000).
   PubMed Web of Science ®Google Scholar
• Simon NM, Otto MW, Wisniewski SR et al. Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am. J. Psychiatry161, 2222–2229 (2004).
   PubMed Web of Science ®Google Scholar
• Jaideep T, Reddy YC, Srinath S. Comorbidity of attention deficit hyperactivity disorder in juvenile bipolar disorder. Bipolar Disord.8, 182–187 (2006).
   PubMedGoogle Scholar
• Mueser KT, Goodman LB, Trumbetta SL et al. Trauma and posttraumatic stress disorder in severe mental illness. J. Consult. Clin. Psychol.66, 493–499 (1998).
   PubMed Web of Science ®Google Scholar
• Zhang H, Wisniewski SR, Bauer MS, Sachs GS, Thase ME. Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) Investigators. Comparisons of perceived quality of life across clinical states in bipolar disorder: data from the first 2000 Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) participants. Compr. Psychiatry47, 161–168 (2006).
   PubMed Web of Science ®Google Scholar
• Comtois KA, Russo JE, Roy-Byrne P, Ries RK. Clinicians’ assessment of bipolar disorder and substance abuse as predictors of suicidal behaviour in acutely hospitalized inpatients. Biol. Psychiatry56, 757–763 (2004).
   PubMed Web of Science ®Google Scholar
• Singh J, Mattoo SK, Sharan P, Basu D. Quality of life and its correlates in patients with dual diagnosis of bipolar affective disorder and substance dependence. Bipolar Disord.7, 187–191 (2005).
   PubMed Web of Science ®Google Scholar
• McLeod LD, Fehnel SE, Wills MM, Hamm LR, Gilchrist KA. Psychometric validation of a patient-reported instrument assessing functional status in bipolar disorder. Poster presented at: the International Society for Quality of Life Research (ISOQOL), San Francisco, CA, USA, October (2005).
   Google Scholar
• Kring Am, Kerr SL, Smith DA, Neale JM. Flat affect in schizophrenia does not reflect diminished subjective experience of emotion. J. Abnorm. Psychol.102, 507–517 (1993).
   PubMed Web of Science ®Google Scholar
• Morgado A, Smith M, Lecrubier Y, Widlocher D. Depressed subjects unwittingly over-report poor social adjustment which they reappraise when recovered. J. Nerv. Ment. Dis.179, 614–619 (1991).
   PubMedGoogle Scholar
• McHorney CA, Kosinski M, Ware JE. Comparisons of the costs and quality of norms for the SF-36 Health Survey collected by mail versus telephone interview: results from a national survey. Med. Care32, 551–567 (1994).
   PubMed Web of Science ®Google Scholar
• Arnold LM, Witzeman KA, Swank ML et al. Health-related quality of life using the SF-36 in patients with bipolar disorder compared with patients with chronic back pain and the general population. J. Affect. Disord.57, 235–239 (2000).
   PubMed Web of Science ®Google Scholar
• Have M, Vollebergh W, Bijl R, Nolen WA. Bipolar disorder in the general population in The Netherlands (prevalence, consequences and care utilisation): results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS). J. Affect. Disord.68, 203–213 (2002).
   PubMed Web of Science ®Google Scholar
• Yatham LN, Lecrubier Y, Fieve RR et al. Quality of life in patients with bipolar I depression: data from 920 patients. Bipolar Disord.6, 379–385 (2004).
   PubMed Web of Science ®Google Scholar
• Leidy NK, Palmer C, Murray M et al. Health-related quality of life assessment in euthymic and depressed patients with bipolar disorders. Psychometric performance of four self-report measures. J. Affect. Disord.48, 207–214 (1998).
   PubMed Web of Science ®Google Scholar
• Endicott J, Nee J, Harrison W, Blumenthal R. Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacol. Bull.29, 321–326 (1993).
   PubMed Web of Science ®Google Scholar
• Ozer S, Ulusahin A, Batur S et al. Outcome measures of interepisode bipolar patients in a Turkish sample. Soc. Psychiatry Psychiatr. Epidemiol.37, 31–37 (2002).
   PubMed Web of Science ®Google Scholar
• Michalak EE, Yatham LN, Wan DD, Lam RW. Perceived quality of life in patients with bipolar disorder. Does group psychoeducation have an impact? Can. J. Psychiatry50, 95–100 (2005).
   PubMed Web of Science ®Google Scholar
• Calabrese JR, Hirschfeld RM, Reed M et al. Impact of bipolar disorder on a US community sample. J. Clin. Psychiatry64, 425–432 (2003).
   PubMed Web of Science ®Google Scholar
• Calabrese JR, Hirschfeld RM, Frye MA, Reed ML. Impact of depressive symptoms compared with manic symptoms in bipolar disorder: results of a US community-based sample. J. Clin. Psychiatry65, 1499–1504 (2004).
   PubMed Web of Science ®Google Scholar
• Thase ME, McCoy R, Chang W, Macfadden W. Efficacy of quetiapine monotherapy in bipolar depression: a confirmatory double-blind, placebo-controlled study (the BOLDER II trial). Poster presented: at the American Psychiatric Association’s 159th Annual Meeting. Toronto, Canada, 20–25 May (2006).
   Google Scholar
• Russo J, Roy-Byrne P, Reeder D et al. Longitudinal assessment of quality of life in acute psychiatric inpatients: reliability and validity. J. Nerv. Ment. Dis.185, 166–175 (1997).
   PubMed Web of Science ®Google Scholar
• Vojta C, Kinosian B, Glick H, Altshuler L, Bauer MS. Self-reported quality of life across mood states in bipolar disorder. Compr. Psychiatry.42, 190–195 (2001).
   PubMed Web of Science ®Google Scholar
• MacQueen GM, Young LT, Robb JC et al. Effect of number of episodes on wellbeing and functioning of patients with bipolar disorder. Acta Psychiatr. Scand.101, 374–381 (2000).
   PubMed Web of Science ®Google Scholar
• Ritsner M, Kurs R, Kostizky H et al. Subjective quality of life in severely mentally ill patients: a comparison of two instruments. Qual. Life Res.11, 553–561 (2002).
   PubMed Web of Science ®Google Scholar
• Atkinson M, Zibin S, Chuang H. Characterizing quality of life among patients with chronic mental illness: a critical examination of the self-report methodology. Am. J. Psychiatry154, 99–105 (1997).
   PubMed Web of Science ®Google Scholar
• Chand PK, Mattoo SK, Sharan P. Quality of life and its correlates in patients with bipolar disorder stabilized on lithium prophylaxis. Psychiatry Clin. Neurosci.58, 311–318 (2004).
   PubMed Web of Science ®Google Scholar
• Dean BB, Gerner D, Gerner RH. A systematic review evaluating health-related quality of life, work impairment, and health-care costs and utilization in bipolar disorder. Curr. Med. Res. Opin.20, 139–154 (2004).
   PubMed Web of Science ®Google Scholar
• Murray CJ, Lopez AD. Global mortality, disability and the contribution of risk factors: Global Burden of Disease Study. Lancet349, 1436–1442 (1997).
   PubMed Web of Science ®Google Scholar
• Wells KB, Sherbourne CD. Functioning and utility for current health of patients with depression or chronic medical conditions in manages, primary care practices. Arch. Gen. Psychiatry56, 897–904 (1999).
   PubMed Web of Science ®Google Scholar
• Berlim MT, Pargendler J, Caldieraro MA et al. Quality of life in unipolar and bipolar depression: are there significant differences? J. Nerv. Ment. Dis.192, 792–795 (2004).
   PubMed Web of Science ®Google Scholar
• Goldberg JF, Harrow M, Grossman LS. Course and outcome in bipolar affective disorder: a longitudinal follow-up study. Am. J. Psychiatry152, 379–384 (1995).
   PubMed Web of Science ®Google Scholar
• Bowden CL, Grunze H, Mullen J et al. A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder. J. Clin. Psychiatry66, 111–121 (2005).
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Brecher M, Paulsson B et al. Quetiapine or haloperidol as monotherapy for bipolar mania – a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial. Eur. Neuropsychopharmacol.15, 573–585 (2005).
   PubMed Web of Science ®Google Scholar
• Vieta E, Mullen J, Brecher M, Paulsson B, Jones M. Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies. Curr. Med. Res. Opin.21, 923–934 (2005).
   PubMed Web of Science ®Google Scholar
• Sachs G, Chengappa KNR, Suppes T et al. Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study. Bipolar Disord.6, 213–223 (2004).
   PubMed Web of Science ®Google Scholar
• Yatham LN, Paulsson B, Mullen J, Vagero M. Quetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar mania. J. Clin. Psychopharmacol.24, 599–606 (2004).
   PubMed Web of Science ®Google Scholar
• Cohen LS.Statistical Power Analysis for the Behavioral Sciences. Erlbaum, NJ, USA (1988).
   Google Scholar
• Shi L, Namjoshi MA, Zhang F et al. Olanzapine versus haloperidol in the treatment of acute mania: clinical outcomes, health-related quality of life and work status. Int. Clin. Psychopharmacol.17, 227–237 (2002).
   PubMed Web of Science ®Google Scholar
• Namjoshi MA, Rajamannar G, Jacobs T et al. Economic, clinical, and quality-of-life outcomes associated with olanzapine treatment in mania. Results from a randomized controlled trial. J. Affect. Disord.69, 109–118 (2002).
   PubMed Web of Science ®Google Scholar
• Revicki DA, Paramore LC, Sommerville KW et al. Divalproex sodium versus olanzapine in the treatment of acute mania in bipolar disorder: health-related quality of life and medical cost outcomes. J. Clin. Psychiatry64, 288–294 (2003).
   PubMed Web of Science ®Google Scholar
• Namjoshi MA, Risser R, Shi L et al. Quality of life assessment in patients with bipolar disorder treated with olanzapine added to lithium or valproic acid. J. Affect. Disord.81, 223–229 (2004).
   PubMedGoogle Scholar
• Hirschfeld RM, Eerdekens M, Kalali AH et al. An open-label extension trial of risperidone monotherapy in the treatment of bipolar I disorder. Int. Clin. Psychopharmacol.21, 11–20 (2006).
   PubMedGoogle Scholar
• Keck PE, Versiani M, Potkin S et al. Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial. Am. J. Psychiatry160, 741–748 (2003).
   PubMed Web of Science ®Google Scholar
• Calabrese JR, Keck PE, Macfadden W et al. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am. J. Psychiatry162, 1351–1360 (2005).
   PubMed Web of Science ®Google Scholar
• Endicott J, Rajagopalan K, Macfadden W et al. Efficacy of quetiapine in improving quality of life in patients with bipolar depression. Poster presentation at: the 13th Congress of the Association of European Psychiatrist, Munich, Germany, 2–6 April (2005).
   Google Scholar
• Tohen M, Vieta E, Calabrese J et al. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch. Gen. Psychiatry60, 1079–1088 (2003).
   Google Scholar
• Shi L, Namjoshi MA, Swindle R et al. Effects of olanzapine alone and olanzapine/fluoxetine combination on health-related quality of life in patients with bipolar depression: secondary analyses of a double-blind, placebo-controlled, randomized clinical trial. Clin. Ther.26, 125–134 (2004).
   PubMedGoogle Scholar
• Berk M, Berk L. Mood stabilizers and treatment adherence in bipolar disorder: addressing adverse events. Ann. Clin. Psychiatry15, 217–224 (2003).
   PubMedGoogle Scholar
• Morselli PL, Elgie R; GAMIAN-Europe. GAMIAN-Europe/BEAM survey I – global analysis of a patient questionnaire circulated to 3450 members of 12 European advocacy groups operating in the field of mood disorders. Bipolar Disord.5, 265–278 (2003).
   PubMed Web of Science ®Google Scholar
• Dando TM, Keating GM. Quetiapine: a review of its use in acute mania and depression associated with bipolar disorder. Drugs65, 2533–2551 (2005).
   PubMed Web of Science ®Google Scholar
• Thunedborg K, Black CH, Bech P. Beyond the Hamilton depression scores in long-term treatment of manic-melancholic patients: prediction of recurrence of depression by quality of life measurements. Psychother. Psychosom.64, 131–140 (1995).
   PubMed Web of Science ®Google Scholar
• Perlis RH, Miyahara S, Marangell LB et al. (STEP-BD) Long-term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder. Biol. Psychiatry55, 875–881 (2004).
   PubMed Web of Science ®Google Scholar
• Olfson M, Fireman B, Weissman MM et al. Mental disorders and disability among patients in a primary care group practice. Am. J. Psychiatry154, 1734–1740 (1997).
   PubMed Web of Science ®Google Scholar
• Olusina AK, Ohaeri JU. Subjective quality of life in recently discharged Nigerian psychiatric patients. Soc. Psychiatry Psychiatr. Epidemiol.38, 707–714 (2003).
   PubMed Web of Science ®Google Scholar